Sign in
4

Changes in Ownership

agilon health, inc. Filed Acc 0001209191-23-025112

Chief Strategy & Dev. Officer sold 5,500 shares at an average $26.84 ($147,618)

  • Chief Strategy & Dev. Officer acquired 5,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Desai Veeral Chief Strategy & Dev. Officer 2023-04-19 Option exercise 10b5-1 +5,000 $3.00 $15,000 304,585 D: show line 1 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-04-19 Sale 10b5-1 −4,545 $26.82 $121,877 300,040 D: show line 2 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-04-19 Sale 10b5-1 −455 $27.84 $12,666 299,585 D: show line 3 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-04-20 Option exercise 10b5-1 +500 $3.00 $1,500 300,085 D: show line 4 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-04-20 Sale 10b5-1 −500 $26.15 $13,074 299,585 D: show line 5 in the form
Open-market sales · 5,500 sh · avg $26.84 · $147,618

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Desai Veeral Chief Strategy & Dev. Officer 2023-04-19 Option exercise · Options (Rights to Buy) 10b5-1 −5,000 1,515,000 D: show line 6 in the form
Desai Veeral Chief Strategy & Dev. Officer 2023-04-20 Option exercise · Options (Rights to Buy) 10b5-1 −500 1,514,500 D: show line 7 in the form
Loading xslF345X04/doc4.xml…